PAGS enters its Q2 earnings report today carrying a short position that has grown meaningfully — 11.4% of the free float is currently sold short, up roughly 8.5% over the past month — while the stock has shed 6.4% on the week and 2.1% in Tuesday's session alone to close at $8.89. Options traders have quietly tilted more defensive too: the put/call ratio has climbed to 0.40, above its 20-day average of 0.375 and running near its highest reading of the past year. Despite that, the borrow market remains loose — availability is running at 578%, meaning shares to borrow vastly outnumber shares currently lent, and the cost to borrow has eased to below 0.5% — so the short position is comfortable and faces no meaningful squeeze pressure.
The analyst debate is split but has been drifting bearish. Jefferies initiated coverage last month at Hold with a $10.40 target, while UBS — the most persistently bullish voice on the name — trimmed its target from $14 to $12.50 in mid-July, keeping its Buy rating but acknowledging deterioration in the near-term outlook. The valuation case for bulls is stark: PAGS trades at roughly five times earnings and under book value, with an EV/EBITDA barely above 2.5x — metrics that rank in the top 2% of the market on an EV/EBIT basis. Bears counter that those multiples have been cheap for a reason: Brazil's macro backdrop, currency sensitivity, and persistent competitive pressure from have consistently capped any re-rating. STNE itself has fallen 8.6% on the week, suggesting the LatAm fintech complex broadly is under pressure heading into this print.
Insider activity offers a modest counterpoint. An officer — identified as Ricardo Dutra Da Silva — sold roughly 124,000 shares across five trades in mid-to-late July at prices between $9.17 and $9.27. Against that, the Chairman of the Board made two substantial purchases in late March, buying nearly 500,000 shares at around $9.94–$9.99 for a combined outlay of approximately $5 million. On a 90-day net basis, insiders are marginally net buyers in share terms, though the more recent officer selling at levels close to today's price tempers the bullish read. Boston Partners added nearly 3.7 million shares through June, and LSV Asset Management initiated a new position of over 3 million shares — both value-oriented signals that the discount is attracting institutional attention even as momentum flags.
The earnings print will test whether PAGS can demonstrate the margin expansion and volume growth that would give value-focused buyers a catalyst to finally close the gap between the stock's depressed multiple and what analysts across the spectrum still see as fair value north of $10.
See the live data behind this article on ORTEX.
Open PAGS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
